Pharma news
Asia
India’s Drug Technical Advisory Board, which advises the government, has reportedly approved a “track and trace” proposal that will allow Indian consumers to identify whether their medicine is genuine simply by sending a text message. 4 June 2018
Pharma
The Paris Court of First Instance has nullified a supplementary protection certificate covering Gilead’s HIV/AIDS treatment Truvada. 4 June 2018
Americas
Drug companies can take heart from a range of best practices in the battle against counterfeit medicines, as LSIPR finds out. 4 June 2018
Pharma
With Brexit looming, questions are being asked about the future regulatory relationship between the EU and the UK, with life sciences companies wondering how they will be affected. LSIPR reports. 4 June 2018
Africa
Médecins Sans Frontières has welcomed the South African government’s release of a new IP policy, calling it an effort to take off a “patent blindfold”. 1 June 2018
Americas
As Mexico prepares for a presidential election in 2018, pharma IP owners are hoping that the progress made in trade negotiations is not undone. Hector Chagoya of Becerril Coca & Becerril reports. 1 June 2018
Americas
Product development partnerships are likely to provide great opportunities for companies seeking to market biosimilar products in Brazil, where there is a huge reliance on public healthcare. Alice Rayol Sandes of Di Blasi, Parente & Associados has more. 1 June 2018
Americas
Brazil’s patent backlog has long caused concern for IP owners, particularly those in the pharmaceutical industry, but progress is being made, as Kene Gallois and Ricardo Nunes of Daniel Legal & IP Strategy report. 31 May 2018
Asia-Pacific
A court has rejected an appeal by the Australian Competition and Consumer Commission, in a decision which confirmed that deals made by Pfizer in relation to generic cholesterol-lowering medication do not constitute a misuse of its market power. 31 May 2018
Americas
Takeda and Aurobindo have agreed to dismiss a dispute over Aurobindo’s filing of an Abbreviated New Drug Application (ANDA) for a generic version of Prevacid Solutab (lansoprazole). 31 May 2018